title: [Radiographic characteristics of lanthanum carbonate absorption].
abstract: Lanthanum carbonate is a new nonaluminium, noncalcium phosphate binder. The drug is well-tolerated its side-effects seem comparable to those of other phosphate binders. The most frequent side-effects are gastrointestinal complications. Cerny [New England Journal of Medecine 355(2006)1160.] and Kunzendorf have recently reported another effect of lanthanum carbonate based on its radiographic characteristics. We report another case of opacification of the intestine with lanthanum carbonate which underlines some difficulties in the use of this new phosphate binder.
authors.affiliation: Service d'Hémodialyse,Centre Hospitalier Général, Valenciennes, France. vrigneaud-l@ch-valenciennes.fr
authors.forename: Laurence
authors.initials: L
authors.lastname: Vrigneaud
authors.forename: Delphine
authors.initials: D
authors.lastname: Lefèbvre
authors.forename: Alexandre Olive
authors.initials: AO
authors.lastname: Daem
authors.forename: Vincent
authors.initials: V
authors.lastname: Lemaitre
mesh_terms: D000368:Aged; D002614:Chelating Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D054559:Hyperphosphatemia / Q000188:drug therapy* / Q000209:etiology; D007408:Intestinal Absorption; D007410:Intestinal Diseases / Q000139:chemically induced / Q000000981:diagnostic imaging; D007676:Kidney Failure, Chronic / Q000150:complications*; D007811:Lanthanum / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D011859:Radiography
chemical_list: D002614:Chelating Agents; C119467:lanthanum carbonate; D007811:Lanthanum